Exact Mass: 334.1429688

Exact Mass Matches: 334.1429688

Found 19 metabolites which its exact mass value is equals to given mass value 334.1429688, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

2-{4-[1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethan-1-ol

C19H18N4O2 (334.1429688)


   

Pimobendan

4,5-dihydro-6-(2-(4-Methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone

C19H18N4O2 (334.1429688)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents

   

Purple pigment

Purple pigment

C19H18N4O2 (334.1429688)


   

Pimobendan (Vetmedin)

Pimobendan (Vetmedin)

C19H18N4O2 (334.1429688)


   

AZD1080

2-hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile

C19H18N4O2 (334.1429688)


   

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester

C19H18N4O2 (334.1429688)


   

GDC-0879

(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

C19H18N4O2 (334.1429688)


GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM.

   

10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine

10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine

C19H18N4O2 (334.1429688)


   

N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide

N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide

C19H18N4O2 (334.1429688)


   

Pimobendan

Pimobendan

C19H18N4O2 (334.1429688)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents

   

2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile

2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile

C19H18N4O2 (334.1429688)


   

N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide

N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide

C19H18N4O2 (334.1429688)


   

6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine

6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine

C19H18N4O2 (334.1429688)


   

Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate

Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate

C19H18N4O2 (334.1429688)


   

2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

C19H18N4O2 (334.1429688)


   

N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide

N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide

C19H18N4O2 (334.1429688)


   

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid

C19H18N4O2 (334.1429688)


   

(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole

(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole

C19H18N4O2 (334.1429688)


   

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid

C19H18N4O2 (334.1429688)